Literature DB >> 18436818

Zeb1 mutant mice as a model of posterior corneal dystrophy.

Yongqing Liu1, Xiaoyan Peng, Jinlian Tan, Douglas S Darling, Henry J Kaplan, Douglas C Dean.   

Abstract

PURPOSE: The zinc finger transcription factor Zeb1 binds to E-box-like sequences and is important for maintaining repression of epithelial specification genes in vivo. Overexpression of Zeb1 in cancer triggers epithelial-mesenchymal transition, which facilitates metastasis. The mutation of ZEB1 in humans is linked to posterior polymorphous corneal dystrophy (PPCD), in which an epithelial transition of the corneal endothelium is associated with abnormal endothelial proliferation. The purpose of this study is to determine whether Zeb1 null or heterozygous mice may provide an animal model for PPCD.
METHODS: Corneal morphology, protein and mRNA expression, and cell proliferation were compared in wild-type and Zeb1 gene knockout mice by immunostaining, real-time PCR, and BrdU incorporation. mRNA expression in isolated embryo fibroblasts derived from wild-type, Zeb1 heterozygous, and null mice was analyzed by real-time PCR
RESULTS: Zeb1 null mice late in gestation show ectopic expression of epithelial genes in the corneal endothelium and keratocytes, including the basement membrane component COL4A3, which is ectopically expressed by the corneal endothelium in PPCD. These embryos also show abnormal corneal endothelial and keratocyte proliferation, corneal thickening, and corneolenticular and iridocorneal adhesions. Adult Zeb1 heterozygous mice exhibit these same corneal defects. The ectopic expression of epithelial genes extended to embryonic fibroblasts derived from Zeb1 heterozygous and null mice, suggesting that Zeb1 may have a more general role in the suppression of an epithelial phenotype.
CONCLUSIONS: The authors conclude that Zeb1 heterozygous and null mice show features of PPCD and thus should provide an animal model for genetic dissection of pathways contributing to the disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18436818      PMCID: PMC2504018          DOI: 10.1167/iovs.07-0789

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  30 in total

1.  Differential expression and function of members of the zfh-1 family of zinc finger/homeodomain repressors.

Authors:  A A Postigo; D C Dean
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

Review 2.  Epithelial-mesenchymal transitions in development and pathologies.

Authors:  Jean Paul Thiery
Journal:  Curr Opin Cell Biol       Date:  2003-12       Impact factor: 8.382

Review 3.  Alport's syndrome, Goodpasture's syndrome, and type IV collagen.

Authors:  Billy G Hudson; Karl Tryggvason; Munirathinam Sundaramoorthy; Eric G Neilson
Journal:  N Engl J Med       Date:  2003-06-19       Impact factor: 91.245

Review 4.  Mechanisms of TGF-beta signaling from cell membrane to the nucleus.

Authors:  Yigong Shi; Joan Massagué
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

5.  The mouse snail gene encodes a key regulator of the epithelial-mesenchymal transition.

Authors:  E A Carver; R Jiang; Y Lan; K F Oram; T Gridley
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

6.  Missense mutations in COL8A2, the gene encoding the alpha2 chain of type VIII collagen, cause two forms of corneal endothelial dystrophy.

Authors:  S Biswas; F L Munier; J Yardley; N Hart-Holden; R Perveen; P Cousin; J E Sutphin; B Noble; M Batterbury; C Kielty; A Hackett; R Bonshek; A Ridgway; D McLeod; V C Sheffield; E M Stone; D F Schorderet; G C Black
Journal:  Hum Mol Genet       Date:  2001-10-01       Impact factor: 6.150

7.  Novel mutations in the ZEB1 gene identified in Czech and British patients with posterior polymorphous corneal dystrophy.

Authors:  Petra Liskova; Stephen J Tuft; Rhian Gwilliam; Neil D Ebenezer; Katerina Jirsova; Quincy Prescott; Radka Martincova; Marike Pretorius; Neil Sinclair; David L Boase; Margaret J Jeffrey; Panos Deloukas; Alison J Hardcastle; Martin Filipec; Shomi S Bhattacharya
Journal:  Hum Mutat       Date:  2007-06       Impact factor: 4.878

8.  VSX1: a gene for posterior polymorphous dystrophy and keratoconus.

Authors:  Elise Héon; Alex Greenberg; Kelly K Kopp; David Rootman; Andrea L Vincent; Gail Billingsley; Megan Priston; Kimberley M Dorval; Robert L Chow; Roderick R McInnes; Godfrey Heathcote; Carol Westall; John E Sutphin; Elena Semina; Rod Bremner; Edwin M Stone
Journal:  Hum Mol Genet       Date:  2002-05-01       Impact factor: 6.150

9.  Opposing functions of ZEB proteins in the regulation of the TGFbeta/BMP signaling pathway.

Authors:  Antonio A Postigo
Journal:  EMBO J       Date:  2003-05-15       Impact factor: 11.598

10.  Clinicopathologic correlation and genetic analysis in a case of posterior polymorphous corneal dystrophy.

Authors:  Sayoko E Moroi; Parag A Gokhale; Miriam T Schteingart; Alan Sugar; Catherine A Downs; Satoko Shimizu; Charles Krafchak; Nobuo Fuse; Susan G Elner; Victor M Elner; Andrew Flint; Michael P Epstein; Michael Boehnke; Julia E Richards
Journal:  Am J Ophthalmol       Date:  2003-04       Impact factor: 5.258

View more
  27 in total

1.  The Ets transcription factor EHF as a regulator of cornea epithelial cell identity.

Authors:  Denise N Stephens; Rachel Herndon Klein; Michael L Salmans; William Gordon; Hsiang Ho; Bogi Andersen
Journal:  J Biol Chem       Date:  2013-10-18       Impact factor: 5.157

2.  Classification of posterior polymorphous corneal dystrophy as a corneal ectatic disorder following confirmation of associated significant corneal steepening.

Authors:  Anthony J Aldave; Lydia B Ann; Ricardo F Frausto; Catherine K Nguyen; Fei Yu; Irving M Raber
Journal:  JAMA Ophthalmol       Date:  2013-12       Impact factor: 7.389

3.  Analysis of the role of ZEB1 in the pathogenesis of posterior polymorphous corneal dystrophy.

Authors:  Vivek S Yellore; Sylvia A Rayner; Catherine K Nguyen; Rajendra K Gangalum; Zhe Jing; Suraj P Bhat; Anthony J Aldave
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-01-25       Impact factor: 4.799

4.  microRNA-204 modulates chemosensitivity and apoptosis of prostate cancer cells by targeting zinc-finger E-box-binding homeobox 1 (ZEB1).

Authors:  Guanlin Wu; Jian Wang; Guojun Chen; Xing Zhao
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

5.  Zeb1 represses Mitf and regulates pigment synthesis, cell proliferation, and epithelial morphology.

Authors:  Yongqing Liu; Fei Ye; Qiutang Li; Shigeo Tamiya; Douglas S Darling; Henry J Kaplan; Douglas C Dean
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-06-10       Impact factor: 4.799

6.  The PPCD1 mouse: characterization of a mouse model for posterior polymorphous corneal dystrophy and identification of a candidate gene.

Authors:  Anna L Shen; Kathleen A O'Leary; Richard R Dubielzig; Norman Drinkwater; Christopher J Murphy; Charles B Kasper; Christopher A Bradfield
Journal:  PLoS One       Date:  2010-08-16       Impact factor: 3.240

Review 7.  Genetics of corneal endothelial dystrophies.

Authors:  Chitra Kannabiran
Journal:  J Genet       Date:  2009-12       Impact factor: 1.166

8.  Functional impact of ZEB1 mutations associated with posterior polymorphous and Fuchs' endothelial corneal dystrophies.

Authors:  Duk-Won D Chung; Ricardo F Frausto; Lydia B Ann; Michelle S Jang; Anthony J Aldave
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-09-04       Impact factor: 4.799

9.  Heterozygous deletions at the ZEB1 locus verify haploinsufficiency as the mechanism of disease for posterior polymorphous corneal dystrophy type 3.

Authors:  Petra Liskova; Cerys J Evans; Alice E Davidson; Marketa Zaliova; Lubica Dudakova; Marie Trkova; Viktor Stranecky; Nicole Carnt; Vincent Plagnol; Andrea L Vincent; Stephen J Tuft; Alison J Hardcastle
Journal:  Eur J Hum Genet       Date:  2015-10-28       Impact factor: 4.246

Review 10.  Corneal dystrophies.

Authors:  Gordon K Klintworth
Journal:  Orphanet J Rare Dis       Date:  2009-02-23       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.